| [1] |
Ljungman P, Boeckh M, Hirsch HH, et al. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials[J]. Clin Infect Dis, 2017, 64(1):87-91. DOI: 10.1093/cid/ciw668.
|
| [2] |
Warren-Gash C, Childs K, Thornton A, et al. Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C:an observational cohort study[J]. Infection, 2017, 45(2):215-220. DOI: 10.1007/s15010-016-0976-x.
|
| [3] |
Zhou H, Zhu W, Zeng J, et al. Probable rabies virus transmission through organ transplantation, China, 2015[J]. Emerg Infect Dis, 2016, 22(8):1348-1352. DOI: 10.3201/eid2208.151993.
|
| [4] |
Spizzo T, Denner J, Gazda L, et al. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes——chapter 2a:source pigs——preventing xenozoonoses[J]. Xenotransplantation, 2016, 23(1):25-31. DOI: 10.1111/xen.12223.
|
| [5] |
Wynyard S, Nathu D, Garkavenko O, et al. Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand[J]. Xenotransplantation, 2014, 21(4):309-323. DOI: 10.1111/xen.12102.
|
| [6] |
Semaan M, Rotem A, Barkai U, et al. Screening pigs for xenotransplantation:prevalence and expression of porcine endogenous retroviruses in Göttingen minipigs[J]. Xenotransplantation, 2013, 20(3):148-156. DOI: 10.1111/xen.12032.
|
| [7] |
Morozov VA, Morozov AV, Rotem A, et al. Extended microbiological characterization of Göttingen minipigs in the contex of xenotransplantation:detection and vertical transmission of hepatitis E virus[J]. PLoS One, 2015, 10(10):e0139893. DOI:10.1371/journal. pone.0139893.
|
| [8] |
Denner J. Xenotransplantation and hepatitis E virus[J]. Xenotransplantation, 2015, 22(3):167-173. DOI: 10.1111/xen.12156.
|
| [9] |
Meng XJ. From barnyard t of ood table:the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety[J]. Virus Res, 2011, 161(1):23-30. DOI: 10.1016/j.virusres.2011.01.016.
|
| [10] |
Pitkin Z. New phase of growth for xenogeneic-based bioartificial organs[J]. Int J Mol Sci, 2016, 17(9):E1593. DOI: 10.3390/ijms17091593.
|
| [11] |
Kim Y, Lee C. Ribavirin efficiently suppresses porcine nidovirus replication[J]. Virus Res, 2013, 171(1):44-53. DOI: 10.1016/j.virusres.2012.10.018.
|
| [12] |
Wu T, Li SW, Zhang J, et al. Hepatitis E vaccine development:a 14 year odyssey[J]. Hum Vaccin Immunother, 2012, 8(6):823-827. DOI: 10.4161/hv.20042.
|
| [13] |
Sanford BJ, Opriessnig T, Kenney SP, et al. Assessment of the crossprotective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs[J]. Vaccine, 2012, 30(44):6249-6255. DOI: 10.1016/j.vaccine.2012.08.013.
|
| [14] |
Su CA, Iida S, Abe T, et al. Endogenous memory CD8 T cells directly mediate cardiac allograft rejection[J]. Am J Transplant, 2014, 14(3):568-579. DOI: 10.1111/ajt.12605.
|
| [15] |
Taveira A, Ponroy N, Mueller NJ, et al. Entry of human cytomegalovirus into porcine endothelial cells depends on both the cellular vascular origin and the viral strain[J]. Xenotransplantation, 2014, 21(4):324-340. DOI:0.1111/xen.12097.
|
| [16] |
Whitteker JL, Dudani AK, Tackaberry ES. Human fibroblasts are permissive for porcine cytomegalovirus in vitro[J]. Transplantation, 2008, 86(1):155-162. DOI: 10.1097/TP.0b013e31817d4823.
|
| [17] |
Mueller NJ, Fishman JA. Herpesvirus infections in xenotransplantation:pathogenesis and approaches[J]. Xenotransplantation, 2004, 11(6):486-490. DOI: 10.1111/j.1399-3089.2004.00180.x.
|
| [18] |
Mueller NJ, Kuwaki K, Dor FJ, et al. Reduction of consumptive coagulopathy using porcine cytomegalovirus-free cardiac porcine grafts in pig-to-primate xenotransplantation[J]. Transplantation, 2004, 78(10):1449-53. doi: 10.1097/01.TP.0000141361.68446.1F
|
| [19] |
Denner J. Xenotransplantation and porcine cytomegalovirus[J]. Xenotransplantation, 2015, 22(5):329-335. DOI: 10.1111/xen.12180.
|
| [20] |
Kharfan-Dabaja MA, Boeckh M, Wilck MB, et al. Reanalysis of transvax immunogenicity[J]. Lancet Infect Dis, 2013, 13(1):18. DOI:1. 10.1016/S1473-3099(12)70296-7.
|
| [21] |
Schleiss MR. Developing a vaccine against congenital cytomegalovirus (CMV) infection:what have we learned from animal models? where should we go next?[J]. Future Virol, 2013, 8(12):1161-1182. DOI: 10.2217/fvl.13.106.
|
| [22] |
Pass RF, Zhang C, Evans A, et al. Vaccine prevention of maternal cytomegalovirus infection[J]. N Engl J Med, 2009, 360(12):1191-1199. DOI: 10.1056/NEJMoa0804749.
|
| [23] |
Burbelo PD, Ragheb JA, Kapoor A, et al. The serological evidence in humans supports a negligible risk of zoonotic infection from porcine circovirus type 2[J]. Biologicals, 2013, 41(6):430-434. DOI: 10.1016/j.biologicals.2013.09.005.
|
| [24] |
Baró J, Segalés J, Martínez J. Porcine circovirus type 2(PCV2) enteric disease:an independent condition or part of the systemic disease?[J]. Vet Microbiol, 2015, 176(1/2):83-87. DOI: 10.1016/j.vetmic.2015.01.006.
|
| [25] |
Quintana J, Segalés J, Calsamiglia M, et al. Detection of porcine circovirus type 1 in commercial pig vaccines using polymerase chain reaction[J]. Vet J, 2006, 171(3):570-573. DOI: 10.1016/j.tvjl.2004.12.008.
|
| [26] |
Dubin G, Toussaint JF, Cassart JP, et al. Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix:approach and outcome[J]. Hum Vaccin Immunother, 2013, 9(11):2398-2408. doi: 10.4161/hv.25973
|
| [27] |
Heinze J, Plotzki E, Denner J. Virus safety of xenotransplantation:prevalence of porcine circovirus 2(PCV2) in pigs[J]. Ann Virol Res, 2016, 2(3):1023. https://www.jscimedcentral.com/Virology/virology-2-1023.pdf
|
| [28] |
Irgang M, Laue C, Velten F, et al. No evidence for PERV release by islet cells from German landrace pigs[J]. Ann Transplant, 2008, 13(4):59-66. http://www.annalsoftransplantation.com/reprintOrder/index/idArt/880220
|
| [29] |
Yang L, Güell M, Niu D, et al. Genome-wide inactivation of porcine endogenous retroviruses (PERVs)[J]. Science, 2015, 350(6264):1101-1104. DOI: 10.1126/science.aad1191.
|
| [30] |
Kaulitz D, Mihica D, Dorna J, et al. Development of sensitive methods for detection of porcine endogenous retrovirus-C (PERV-C) in the genome of pigs[J]. J Virol Methods, 2011, 175(1):60-65. DOI: 10.1016/j.jviromet.2011.04.017.
|
| [31] |
Denner J, Mihica D, Kaulitz D, et al. Increased titers of neutralizing antibodies after immunization with both envelope proteins of the porcine endogenous retroviruses (PERVs)[J]. Virol J, 2012, 9:260. DOI: 10.1186/1743-422X-9-260.
|
| [32] |
Waechter A, Denner J. Novel neutralising antibodies targeting the N-terminal helical region of the transmembrane envelope protein p15E of the porcine endogenous retrovirus (PERV)[J]. Immunol Res, 2014, 58(1):9-19. DOI: 10.1007/s12026-013-8430-y.
|
| [33] |
Langhammer S, Hübner J, Jarrett O, et al. Immunization with the transmembrane protein of a retrovirus, feline leukemia virus:absence of antigenemia following challenge[J]. Antiviral Res, 2011, 89(1):119-123. DOI: 10.1016/j.antiviral.2010.11.011.
|
Figures(1) / Tables(1)
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: